EFTA02444816.pdf

.4O Quesc Diagnostic QUEST DIAGNOSTICS INCORPORATED CLIENT SERVICE SPECIMEN INFORMATION SPECIMEN: K4671284 REQUISITION: COLLECTED: 03/03/2010 11:50 RECEIVED: 03/03/2010 21:07 REPORTED: 03/09/2010 17:30 PATIENT INFORMATION EPSTE1N,JEFFREY DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: PHONE: REPORT STATUS PARTIAL REPRINT ORDERING PHYSICIAN CLIENT INFORMATION T11886 WOODSON MERRELL. M.D. 44 E 67TH STREET NEW YORK, NY 10065 10013650 The original copy of this report was printed on: 03/09/2010 at 08:16 Patient results contained In a facsimi le or electronic medical report are provided only upon the request of the physician or authorized person. Facsimile or electronic medical reports that are created before the final results are reported are considered to be INTERIM RESULTS ONLY and are subject to change by the laboratory. Test Name In Range Out of Range Reference Range 1GF-1 151 87-Z25 ng/mL FSH 3.7 1.6-8.0 mIU/nL LH 4.1 1.5-9.3 mill/ML PROLACTIN 2.6 2.0-18.0 ng/mL PROGESTERONE 1.1 <1.4 ng/mL DHEA SULFATE 182 25-240 mcg/dL TESTOSTERON,FR/TOT,LCMSMS TESTOSTERONE, TOTAL 188 L 250-1100 ng/dL Total Testosterone was measured by LCMSMS. The LCMSMS method correlates well with our extraction/RIA method. % FREE TESTOSTERONE 1.94 1.5-2.2 % TESTOSTERONE, FREE 7-346.t.i) 35.0-155.0 pg/nL MTHFR,DNA MUTATION.NY see note A RESULT: POSITIVE FOR ?WO COPIES OF THE C677T _) MUTATION DNA testing indicates this individual is homozygous for the C677T mutation and does not have the A1298C mutation. This has been associated with an increased risk for hyperhonocysteinemia and vascular diseases. Consider genetic counseling and DNA testing for at-risk members. EPSTEIN,JEFFREY - K4671284 Lab TBR TBR TBR TBR TBR TBR QNI Page 1 - Continued on Page 2 Intl, Wit lia,bistics, ee 44,4clittd leis as4 all allittotril Osewl Diers$tiff .ifil off thr trilisleks or 0.ril Dulauuf Irgerf*,atfl ill rail's u/va u m IIONIM VI WIPIM 1/6: EFTA_R1_01522013 EFTA02444816 • O Quest Diagnostic", QUEST DIAGNOSTICS INCORPORATED SPECIMEN INFORMATION SPECIMEN: X4671284 COLLECTED: 03/03/2010 REPORTED: 03/09/2010 11:50 17:30 PATIENT INFORMATION EPSTEIN,JEFFREY DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y REPORT STATUS PARTIAL REPRINT ORDERING PHYSICIAN CLIENT INFORMATION T11886 10013650 Test Name In Range Out of Range Reference Range Laboratory testing supervised and results monitored by U.N. Pratt, Ph.D.. FACMG, Director, Molecular Genetics. Hyperhomocysteinemia is a risk factor for arterial disease and venous thrombosis. Homocysteine levels are affected by nutritional and genetic factors. Since MINER is involved in methylation of homocysteine to methionine, individuals with MTHFR gene mutations that reduce enzyme activity may develop hyperhoncysteinenia and thus be at risk for vascular disease. The C677T and A1298C mutations are detected by signal amplification of the MTHFR gene by allele- specific hybridizations and chemi luminescent detection of hybridized probes. Since genetic variation and other factors can affect the accuracy of direct mutation testing, these results should be interpreted in light of clinical and familial data. This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Chantilly, UA. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test. ESTRAD1CL,ULTRASEN,LEMSMS PENDING PERFORMING LABORATORY INFORMATION: AND Quest Diagnostics Nichols Chantilly 14225 Neubrook Drive Chantilly VA Z0151 Laboratory Director: Kenneth Slsco. MD.PhD CLIA No: 4900221801 QN1 Quest Diagnostics, Nichols Institute 33608 Ortega Highway San Juan Capistrano CA 92690 Laboratory Director: Dr. Jon M. Nakamoto CLIA No: 05110643352 1BR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr, M.D. CLIA No: 3100695246 EPSTEIN,JEFFREY - X4671Z84 Page Z - End of Report MOW Wit liet, tit isimiltd ail ill irsocialttl lwl harosItts irks art be Dadasarkt el kept Diatnett In Intrpornd ell riials rtivted Winn VII Lab $141/9 ftle IAMIU V) EFTA_R1_01522014 EFTA02444817 44n Quest Diagnostics) QUEST DIAGNOSTICS INCORPORATED CLIENT SERU10E SPECIMEN INFORMATION SPECIMEN: X4666434 REQUISITION: COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 20:43 REPORTED: 03/08/2010 08:32 PATIENT INFORMATION ESPSTE1N.JEFFREY DOB: 01/28/1953 AGE: 57 GENDER: M FASTING: PHONE: REPORT STATUS FINAL REPRINT ORDERING PHYSICIAN CLIENT INFORMATION 111886 WOODSON MERRELL. M.D. 44 E 67TH STREET NEW YORK. NY 10065 10013650 The original copy of this report was printed on: 03/05/2010 at 08:16 Test Name LEAD, BLOOD In Range Out of Range Reference Range <3 <10 mcg/dL Blood lead levels in the range of 5-9 mcg/dL have been associated with adverse health effects In children aged 6 years and younger. Industrial Exposure: (40 mcg/dL mcg/dL x mcg/100g for OSHA (refer to current governmental regulations for exposure criteria) MERCURY.BLOOD 5 (x10 mcg/L ARSENICAILOOD 4 ¢3 ncg/L Urine is usually the best specimen for the analysis of Arsenic in body fluids. Blood levels tend to be low even when urine concentrations are high. PERFORMING LABORATORY INFORMATION: AND Quest Diagnostics Nichols Chantilly 14225 Newbrook Drive Chantilly VA 20151 Laboratory Director: Kenneth Sisco, MD,PhD CLIA No: 4900221801 TBR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr, M.D. CLIA No: 31D0696246 ESPSTEIN.JEFFREY - K4666434 Page 1 - End of Report frost, frost Input.'., iI, asocatiol loge ad at asocial.' last floristin ear ire no trartutors if Ivor floristic. locaporita. Ill feria anat.. Orlatt. I II 934VA M:31 /11111111 20 Lab TBR AND AMD EFTA_R1_0 1522015 EFTA02444818 PATIENT INFORMATION REPORT STATUS FINAL flak Quest Diagnostict WEST b:AanosTics INCORPORATED CLIENT SERVICE SPECIMEN INFORMATION SPECIMEN: F7579815 REQUISITION: COLLECTED: 03/03/2010 11:50 RECEIVED: 03/03/2010 21:49 REPORTED: 03/05/2010 10:31 EPSTEIN, JEFFREY DOD: 01/20/1953 AGE: 57 GENDER: M FASTING: Y PHONE: ORDERING PNUIcIAN CLIENT INFORMATION T11886 WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 10013650 Test Name CALCIUM FTIGINTACT Interpretive Guide Normal Parathyroid Function Hypoparathyroidism Primary Hyperparathyroidism Secondary Hyperparathyroidism Tertiary Hyperparathyroidism Non-Parathyroid Hypercalcemia In Range Out of 8.9 Intact PT Normal Low or Low Normal Normal or High High High Low or Low Normal PERFORMING LABORATORY INFORMATION: TBR *Nest Diagnostics One Malcolm Avenue Teterboro CLIA No: 3100696246 EPSTEIN,JEFFREY - F7579815 Range Reference Range 8.6-10.2 mg/dL H 10-65 pg/mL Calcium Normal Low High Normal or Low High High NJ 07608 Laboratory Director: William E Tarr. M.D. Page 1 - End of Report Lab TBR TER Dog Cunt Perm. /]snot vs< kgnei N..sww Lest Wichill en. Mae Sera. RoiltDersagii On411/4 .631.0 MW0MIWN At •ro tattosell .Old SU sot lot, EFTA_R1_01522016 EFTA02444819 tar? Quest te r Diagnostics Date of Report: 01/06/2010 Patient Name: Jeffrey Epstein Identification Number: Age: 57 Sex: M Intact Parathyroid Hormone Test No. 1222A Date Received: 03103/2010 Accession II F7579815 Results (Please refer to the official Medical Report) Intact PTH 68.90 pg/mL I Normal Range 10 - 65 pg/mL) Total Calcium 10.40 mg/dL (Female Range 8.5 - 10.3 mg/c1L- Male Range 8.7 - 10.4 mg/d1 ) Legend Normal Indeterminate Secondary Hyperparathyroidism Primary Hyperparathyroidism Hypoparathyroidism Non-Parathyroid Hypercalcomia gest Diagnostics One Malcolm Avenue Tetedxso New Jersey 07608-1070 T11886 10013650 WOODSON MERRELL, M.D. 44 E 67th Street New York, NY 10065 too® 9000 axe 7000 6000 5000 4000 1000 900 BOO 700 600 SOO 403 E -a, no 5 100 : .c 0. 4 •€ 50L I I Note: The reference range on the graph may differ from the reference range cited for this patient. The comparison data set on the back of this report includes both male and female patients. The reference ranges for calcium on the graph are those that would be applied to an adult patient where sex was unspecified. 10 9 a 7 6 3 QuestTrack Intact Parathyroid Hormone Ordering Physician: Route: 10013650 Account Number: TI IMO 170 140 2.0 4.0 6.0 6.0 100 C 2002 Gam Dmonomics Incorporad VIM 11$0.Ved Calcium tmg/d0 Oust Oust 0.40444044, en moons logo and all assevabse Guest Diagnostics marks We Ihe trilidemel• of Quest (Ns irost ,t s I ^c ()wilted 160 EFTA_R1_01522017 EFTA02444820 4IPlk Quest ja4, Diagnostic PATIENT INFORMATION EPSTEIN, JEFFREY QUEST DIAGNOSTICS INCORPORATED CLIENI' SERVICE DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION SPECIMEN: 92116012 REQUISITION: COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 19:57 REPORTED: 03/08/2010 08:16 PHONE: REPORT STATUS FINAL ORDERING PHYSICIAN Chi 2N7 INFORmAT ION T11886 WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 10013650 Test Name In Range Out of Range Reference Range Lab MAGNESIUM 1.8 1.5-2.5 mg/dL TBR TSH,3RD GENERATION 1.77 0.40-4.50 mIU/L TBR THYROID PANEL TBR T4,TOTAL 9.4 4.5-12.5 mcg/dL Please note new reference range. T3 UPTAKE 32 22-35 Percent T4,FREE,CALCULATED 3.0 1.4-3.8 Units CK,TOTAL 262 1 H 44-196 U/L TBR EPSTEIN,JEFFREY - 92116012 Page 1 - Continued on Page 2 Bost Os Owens S ass sd me, ol atellAjitC Cam illsso. st , w, imp Nash rip Os Wyss i Est Swots swoops./ A I MS 'sits! 111)211:0417L M. nai SOB SCN ISM EFTA_R1_01522018 EFTA02444821 ak Quest Diagnostic® PAT [ENT INFORMATION EPSTEIN, JEFFREY DIAGNGSTICS INCORPORATED DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y MIN INFORMATION CIMIN: 92116012 LECTED: 03/03/2010 08:20 URTED: 03/08/2010 08:16 REPORT STATUS FINAL ORDERING PHYSICIAN CLIENT IN FORK* r ION T11886 10013650 sat Name S/HDL/TIBC W FER RFX/FRUCTOSAMINE GLUCOSE, FASTING FRUCTOSAMINE SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE UREA NITROGEN CREATININE BUN/CREATININE RATIO Bun/Creatinine ratio is not reported when Creatinine values are within normal/14 its. t8.6 In Range Out of Range Reference Range URIC ACID PHOSPHORUS CALCIUM CHOLESTEROL, TOTAL HDL CHOLESTEROL CHOLESTEROL/HDL'RATIO LDL CHOL, CALCULATED See footnote 1 TRIGLYCERIDES PROTEIN, TOTAL ALBUMIN GLOBULIN, CALCULATED A/G RATIO BILIRUBIN,TOTAL BILIRUBIN, DIRECT ALKALINE PHOS PHATASE GGT AST ALT LD IRON, TOTAL TIBC TRANSFERRIN SATURATION PIEIN,JEFFREY - 92116012 246 140 4.4 105 24 18 0.94 NOTE 3.3 10.0 200 111 7.4 4.6 2.8 1.6 0.7 0.1 64 12 21 19 152 70 314 22 e04) the Bun H L H H 65-99 mg/dL 190-270 umol/L 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 21-33 mmol/L 7-25 mg/dL 0.76-1.46 mg/dL 6-22 and 4.0-8.0 mg/dL 2.5-4.5 mg/dL 8.6-10.2 mg/dL 125-200 mg/dL >=40 mg/dL < = 5.0 <130 mg/dL <150 mg/dL 6.2-8.3 g/dL 3.6-5.1 g/dL 2.1-3.7 g/dL 1.0-2.1 0.2-1.2 mg/dL < = 0.2 mg/dL 40-115 U/L 3-85 U/L 10-35 U/L 9-60 U/L 120-250 U/L 45-170 mcg/dL 250-425 mcg/dL 20-50 % Page 2 - Continued on Page 3 &OK 'Ma DOOPWICI OW • 510141•1 CIF MeM ais+cal Dest Dwyer"' • nen Pe the •••••••••As v Ores. 0u,rnU c 0•040$1•LtilliV 'Aid At oath gown. C031100.NYI Peva/IV* dlOt New Lab TB?? EFTA_R1_01522019 EFTA02444822 Ank Quest Diagnostics PATIENT INFORMATION EPSTEIN, JEFFREY WEST DIAGNOSTICS INCORPORATED DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION SPECIMEN: 92116012 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 REPORT STATUS FINAL ORDERING "21. I 1:N: IN f", ,MA71r-N T11886 10013650 Teat Name CBC (INCLUDES DIFF/PLT) WBC RBC HEMOGLOBIN HEMATOCRIT MCV MCH MCHC RDW PLATELET COUNT MPV TOTAL NEUTROPHILS,t TOTAL LYMPHOCYTES,t MONOCYTES,t EOSINOPHILS,t BASOPHILS,% NEUTROPHILS,ABSOLUTE LYMPHOCYTES, ABSOLUTE MONOCYTES, ABSOLUTE EOSINOPHILS,ABSOLUTE BASOPHILS,ABSOLUTE DIFFERENTIAL An instrument differential In Range URINALYSIS, COMPLETE COLOR APPEARANCE GLUCOSE, QL BILIRUBIN, URINE KETONES SPECIFIC GRAVITY BLOOD PH PROTEIN, TOTAL, QL NITRITE LEUKOCYTE ESTERASE SQUAMOUS EPITHELIAL CELLS WBC BACTERIA RBC HYALINE CASTS EPSTEIN,JEFFREY - 92116012 5.3 5.06 15.0 44.8 88.5 29.6 33.4 13.4 289 7.9 49.7 34.9 7.5 7.2 0.7 2634 1850 398 382 37 Out of Range Reference Range was performed. Yellow Negative Negative Negative 1.024 5.5 Negative Negative Negative None Seen None Seen None Seen None Seen Cloudy • t19 (1+) 3.8-10.8 ThOus/mCL 4.20-5.80 Mill/mcL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thous/mcL 7.5-11.5 fL 38-80 % 15-49 % 0-13 % 0-8 % 0-2 % 1500-7800 Cells/mcL 850-3900 Cells/mcL 200-950 Cells/mcL 15-550 Cells/mcL 0-200 Cells/mcL Yellow Clear Negative mg/dL Negative Negative mg/dL 1.001-1.035 • Negative 5.0-8.0 Negative mg/dL Negative Negative cor=5 cells/hpf cor=5 cells/hpf None Seen /hpf corn3 cells/hpf None Seen /lpf Page 3 - Continued on Page 4 0.4ot rhas0,49.6n. no ow, oo, nx nMrMeiGw.ly.m...mt non. R ono ••kl•Oill V al ..)oregone • 40,N lextra, °owner re ...item rows. OMIXONTIL qtrs." 91/1 Sac Lab TBR TBR EFTA_R1_01522020 EFTA02444823 Ank Quest 6 74 Diagnostics QUEST DIAGNOSTICS INCORPORATED SPECIMEN INPUSMNP:ON SPECIMEN: 92116012 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 PATIENT INFORMATION EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y REPORT STATUS FINAL ORDERING PHYSICIAN CLIENT INFORMATION T11886 10013650 Test Name In Range Out of Range Reference Range Lab VITAMIN B12 4. FOLATE VITAMIN B12,SERUM Q5/3) 200-1100 pg/mL Please note: although the reference range for Vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1% of patients with values above 400 pg/mL will have symptoms. FOLATE,SERUM 10.6 > 5.4 ng/mL Normal: >5.4 Borderline: 3.4.5.4 Low: <3.4 TBR CARDIO CRP (R) 0.8 mg/L TBR Low relative cardiovascular risk according to AHA/CDC guidelines. See footnote 2 PSA, TOTAL See footnote 3 0.54 <=4.0 ng/mL TBR APOLIPOPROTEIN A -1+B TBR APOLIPOPROTEIN Al 117 __ 94-176 mg/dL APOLIPOPROTEIN B 107 52-109 mg/dL APOLIPOPROTEIN B/A1 RATIO 0.91 Below average risk: Average risk: Above average risk: HEMOGLOBIN AlC HOMOCYSTEINE, CARDIO HOMOCYSTEINE <0.29 0.29-1.30 >1.30 Reference Range: Non Diab H Percent 6.0% 11: <11.4 M/CROmol/L EPSTEIN, JEFFREY - 92116012 Page 4 - Continued on Page 5 0 so. Choi Papenta Imp +.4 a. ea Pora*.• ^Phi st• PaNn." CNN, 0NV*Pcs t CUM, 0.91.11< 10(01W. WA A ' ,nano/ 0DNOWNTL SP SUS ISSN TBR TBR EFTA_R1_01522021 EFTA02444824 e Quest Diagnostics QUEST DIAGNOSTICS INCORPORATED SPECIMEN INFORMATION SPECIMEN: 92116012 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 PAV.F.NT EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y REPORT STATUS FINAL ORDERING PHYSICIAN CLIENT INFORMATION T11886 10013650 Test Name In Range Out of Range Reference Rang. Lab VITAMIN D,25-0H,LC/MS/MS VITAMIN D, 25-0H, TOTAL 42 20-100 ng/mL VITAMIN D, 25-OH, D3 42 ng/mL VITAMIN D, 25-OH, D2 <4 ng/mL 25-OHD3 indicates both endogenous production and supplementation. 25-OHD2 is an indicator of exogenous sources such as diet or supplementation. Therapy is based on measurement of Total 25-OHD, with levels <20 ng/mL indicative of Vitamin D deficiency, while levels between 20 ng/mL and 30 ng/mL suggest insufficiency. Optimal levels are >30 ng/mL. MAGNESIUM,RBC 4.6 FOOTNOTE(S): 1 TBR 4.0-6.4 mg/dL AMD Desirable range is <100 mg/dL for patients with coronary heart disease (CHD) or diabetes, and <70 mg/dL for diabetic patients with known CHD. 2 For Ages >17 Years: 3 CCRP mg/L Risk according to AHA/CDC guidelines <1.0 Low cardiovascular risk 1.0 - 3.0 Average cardiovascular risk 3.1 - 10.0 High cardiovascular risk >10.0 Persistent elevations may represent non-cardiovascular inflammation This test was performed using the Siemens (Bayer) chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. PERFORMING LABORATORY INFORMATION: AMD Quest Dtagnostics Nichpls Chanc,lly 14225 NewbrOOK Drive Chantilly VA 20151 Laboratory Director: Kenneth Risco, MD,PhD CLIA No: 49D0221801 113R Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr. M.D. CLIA No: 3100696246 EPSTEIN,JEFFREY - 92116012 Page 5 - End of Report Owg.tlauti.n...“ 7r anway, ur Ind a 40-CifrIlaudaltrinitrrar r•tkeesitasitaaGuu.aribbot• I. nt pearl Airrarmer.< aommeratfteemn. SCA mewl EFTA_R1_01522022 EFTA02444825 441% Quest Diagnostics PATIENT INFORMATION EPSTEIN, JEFFREY QUEST DIAGNCSTIcS INCORPORATED CLIENT SERVICE DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION SPECIMEN: P7579848 REQUISITION: COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 21:52 REPORTED: 03/08/2010 08:16 PHONE: REPORT STATUS FINAL ORDERING PHYSICIAN CLIENT INFORMATION T11886 WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 10013650 Test Name In Range Out of Range Reference Range Lab INSULIN,FREE 7.8 Insulin levels vary widely in specimens taken from non-fasting individuals. 1.5-14.9 uIU/mL QNI PERFORMING LABORATORY INFORMATION: QNI Quest Oiagnostics. Nichols Institute 2760E Ortega Highway San Juan Capistrano CA 92690 LabOratOry Director: Dr. Jon N. Nekamoto CLIA No: 050643152 EPSTEIN,JEFFREY - F7579848 Page 1 - End of Report Chats' aaWD.I..104. .1.,..elin•ra ...Ana. city Meo Onwon sets of TI.t rmlivtis el 114.,Davuour t. asul>.ipaibeebtwante• Al Ihronne int 0020IWIL AteseJtil 501 USA EFTA_R1_01522023 EFTA02444826